Impact of Dose-Escalated Chemoradiation on Quality of Life in Patients With Locally Advanced Rectal Cancer

Autor: Onne Reerink, Maaike Berbee, J.P. Maarten Burbach, Anke B. Smits, Joost T. Heikens, H. Lenny M. Verkooijen, W. Helma M.U. van Grevenstein, Jeroen Buijsen, Martijn Intven, S. Hoendervangers, Maaike E. Verweij, Alice M. Couwenberg, Jeanine M.L. Roodhart, Esther C. J. Consten, Apollo Pronk

Publikováno v: International Journal of Radiation Oncology Biology Physics, 112(3). ELSEVIER SCIENCE INC
International Journal of Radiation Oncology Biology Physics, 112(3), 694-703. Elsevier Science

Purpose: Dose-escalated chemoradiation (CRT) for locally advanced rectal cancer did not result in higher complete response rates but initiated more tumor regression in the randomized RECTAL-BOOST trial (Clinicaltrials.gov NCT01951521). This study com

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5ef480108933dd0650cb7757c7e4bbb
https://doi.org/10.1016/j.ijrobp.2021.09.052